Sage Therapeutics, Inc. is a biopharmaceutical company. The Company has developed two FDA-approved treatments indicated for postpartum depression (PPD) and is advancing a portfolio of internally discovered novel chemical entities with the potential to become differentiated treatments designed to improve brain health by primarily targeting two critical central nervous system, receptor systems, GABA and NMDA. Its product ZURZUVAE is for the treatment of PPD in adults. ZURZUVAE is a neuroactive steroid that is a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors, and is the first oral, once-daily, 14-day treatment specifically indicated for adults with PPD. It is also evaluating potential indications for SAGE-324, a novel GABAA receptor positive allosteric modulator intended for chronic oral dosing, including seizures in developmental and epileptic encephalopathies. Its other areas of focus are SAGE-319, SAGE-039, and SAGE-817.
What is the share price of Sage Therapeutics Inc today?
Sage Therapeutics Inc (SAGE) share price as of April 3, 2026 is $8.68. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Sage Therapeutics Inc?
Yes, Indian Investors can invest in the Sage Therapeutics Inc (SAGE) Share by opening an international trading account with Angel One.
How can I purchase Sage Therapeutics Inc shares in India?
Purchasing Sage Therapeutics Inc (SAGE) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Sage Therapeutics Inc (SAGE) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Sage Therapeutics Inc?
Yes, you can purchase fractional shares of Sage Therapeutics Inc (SAGE) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Sage Therapeutics Inc?
The market capitalization of Sage Therapeutics Inc on February 11, 2026, is $-.
In which sector Sage Therapeutics Inc belongs?
Sage Therapeutics Inc operates in the Healthcare sector, specifically in the Biotechnology industry.
What documents are required to invest in Sage Therapeutics Inc stocks?
In order to invest in Sage Therapeutics Inc (SAGE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
